ADC Therapeutics enters licence option dea...ADC Therapeutics SA has entered a R&D pact with Affimer developer Avacta Group plc aimed at creating and licencing Affimer drug conjugates. more ➔
Novo Nordisk enters haemophilia gene thera...Licencing bluebird bios Inc know-how and technology in one-time gene therapies, Novo Nordisk A/S tries to get a foothold in the emerging haemophilia A gene therapy market. more ➔
Evotec and Celmatix enter strategic partne... Evotec SE has expanded its drug discovery customer base with US women’s health specialist Celmatix Inc. more ➔
Qiagen/Illumina: Earthquake in NGS IVD mar...QIAGEN and Illumina join forces in the next-gen sequencing-based IVD testing and companion diagnostics market announcing a 15-year collaboration. more ➔
Researchers unravel how ADEP antibiotics w...German researchers have determined the mechanism of a ADEPs, a novel class of antibiotics, allowing for pharmacological optimisation. more ➔
New method allows tracking of HIVA new method allows real-time-visualisation of how the HI virus spreads between living T helper cells and which molecules it requires for this purpose. more ➔
Successful EFIB in BrusselsHow can biotechnology and bioeconomy contribute to establish a sustainable and circular economy? Nearly 500 attendees discussed latest trends at EFIB 2019 in Brussels. more ➔
Rottapharm Biotech: POC in osteoarthritis...Rottapharm Biotech (Monza, Italy) has published detailed results from a clinical Phase II trial of CR4056 in chronic pain from knee osteoarthritis. more ➔
Spanish sector attracting more and more in...Spain’s biotech association Asebio announced new record numbers from its biotech investor day held as part of the European Biotech Week. more ➔
Creoptix AG closes CHF8m financing round Swiss drug discovery analytics specialist Creoptix AG has raised CHF8m in a Series C financing for commercial expansion. more ➔
